NCT02089438View on ClinicalTrials.gov

DPP-4 Inhibition, Incretins and Islet Function

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

June 30, 2017

Study Completion Date

August 31, 2017

Conditions
Type 2 Diabetes
Interventions
DRUG

Saxagliptin

Saxagliptin (5 mg) is given before breakfast

DRUG

Vildagliptin

Vildagliptin (50mg) is given before breakfast and dinner

DRUG

Sitagliptin

Sitagliptin (100 mg) is given before breakfast

Trial Locations (1)

22185

Clinical Research Department, Lund

All Listed Sponsors
lead

Lund University

OTHER

NCT02089438 - DPP-4 Inhibition, Incretins and Islet Function | Biotech Hunter | Biotech Hunter